TACSTD2 and neoplasm: The hRS7 antibody could bind directly to TROP-2-expressing tumor cells and trigger the internalization of the SGs, leading to hydrolysis of the CL2A linker and release of the topoisomerase I inhibitor, SN-38, thereby inducing DNA damage and ultimately apoptosis.